Synthesis of new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides via directed ortho-metalation reaction

Yakdhane Kacem; Abderrahman Bouraoui; Virginie Ratovelomanana-Vidal; Jean-Pierre Genet; Béchir Ben Hassine

doi:10.1016/S1631-0748(02)01418-2

Synthesis of new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides via directed ortho-metalation reaction
[Synthèse de nouveaux 1,1-dioxydes de 2H-1,2-naphtothiazin-4(3H)-one 3-substitués via la réaction de métallation ortho-dirigée.]

Yakdhane Kacem ¹ ; Abderrahman Bouraoui ² ; Virginie Ratovelomanana-Vidal ³ ; Jean-Pierre Genet ³ ; Béchir Ben Hassine ¹

¹ Laboratoire de synthèse organique asymétrique et catalyse homogène, faculté des sciences de Monastir, av. de l’Environnement, 5019 Monastir, Tunisie
² Laboratoire de pharmacologie, faculté de pharmacie de Monastir 5000, Tunisie
³ Laboratoire de synthèse sélective organique et produits naturels, École nationale supérieure de chimie de Paris, 11, rue Pierre-et-Marie-Curie, 75231 Paris cedex 05, France

Comptes Rendus. Chimie, Volume 5 (2002) no. 8-9, pp. 611-621.

Résumés

Anglais
Français

The reaction of compounds 6a–i, readily available from α-amino acids, with an excess of lithium diisopropylamide, leads to new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a–i, with yields ranging between 21 and 70%. The key steps are: the naphthylsulfonyl ortho-deprotonation based on the directed ortho-metalation reaction followed by a regiospecific intramolecular cyclisation reaction. Lithiation–deuteration experiments carried out on the naphthylsulfonamides 8 and 9 using n-BuLi and LDA demonstrated the regioselectivity of the deprotonation of the H-3 over the H-1 one of the naphthalene ring.

La réaction des composés 6a–i, facilement obtenus à partir acides α-aminés, en présence d’un excès de diisopropylamide de lithium, conduit à de nouveaux 1,1-dioxydes de 2H-1,2-naphtothiazin-4(3H)-one 3-substituées 7a–i, avec des rendements entre 21 et 70%. Les étapes clés sont : la déprotonation ortho du naphtylsulfonyle, basée sur la réaction de métallation ortho dirigée, suivie par une réaction de cyclisation intramoléculaire régiospécifique. Des expériences de lithiation–deutération menées sur les naphthylsulfonamides secondaires et tertiaires 8 et 9 en présence de n-BuLi et de LDA ont démontré le caractère régiospécifique de la déprotonation du proton H-3 sur le proton H-1 du cycle naphthalène.

Métadonnées

Reçu le : 2002-10-11
Accepté le : 2002-10-11
Publié le : 2002-08-01

DOI : 10.1016/S1631-0748(02)01418-2

Keywords: regiospecificity, cyclisation, metalation, deprotonation, deuteration
Mots-clés : régiospécificité, cyclisation, métallation, déprotonation, deutération

Affiliations des auteurs :

Yakdhane Kacem ¹ ; Abderrahman Bouraoui ² ; Virginie Ratovelomanana-Vidal ³ ; Jean-Pierre Genet ³ ; Béchir Ben Hassine ¹

¹ Laboratoire de synthèse organique asymétrique et catalyse homogène, faculté des sciences de Monastir, av. de l’Environnement, 5019 Monastir, Tunisie
² Laboratoire de pharmacologie, faculté de pharmacie de Monastir 5000, Tunisie
³ Laboratoire de synthèse sélective organique et produits naturels, École nationale supérieure de chimie de Paris, 11, rue Pierre-et-Marie-Curie, 75231 Paris cedex 05, France

@article{CRCHIM_2002__5_8-9_611_0,
     author = {Yakdhane Kacem and Abderrahman Bouraoui and Virginie Ratovelomanana-Vidal and Jean-Pierre Genet and B\'echir Ben Hassine},
     title = {Synthesis of new {3-substituted-2<strong>\protect\emph{H}</strong>-1,2-naphthothiazin-4(3<strong>\protect\emph{H}</strong>)-one} 1,1-dioxides via directed ortho-metalation reaction},
     journal = {Comptes Rendus. Chimie},
     pages = {611--621},
     publisher = {Elsevier},
     volume = {5},
     number = {8-9},
     year = {2002},
     doi = {10.1016/S1631-0748(02)01418-2},
     language = {en},
}

TY  - JOUR
AU  - Yakdhane Kacem
AU  - Abderrahman Bouraoui
AU  - Virginie Ratovelomanana-Vidal
AU  - Jean-Pierre Genet
AU  - Béchir Ben Hassine
TI  - Synthesis of new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides via directed ortho-metalation reaction
JO  - Comptes Rendus. Chimie
PY  - 2002
SP  - 611
EP  - 621
VL  - 5
IS  - 8-9
PB  - Elsevier
DO  - 10.1016/S1631-0748(02)01418-2
LA  - en
ID  - CRCHIM_2002__5_8-9_611_0
ER  -

%0 Journal Article
%A Yakdhane Kacem
%A Abderrahman Bouraoui
%A Virginie Ratovelomanana-Vidal
%A Jean-Pierre Genet
%A Béchir Ben Hassine
%T Synthesis of new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides via directed ortho-metalation reaction
%J Comptes Rendus. Chimie
%D 2002
%P 611-621
%V 5
%N 8-9
%I Elsevier
%R 10.1016/S1631-0748(02)01418-2
%G en
%F CRCHIM_2002__5_8-9_611_0

Yakdhane Kacem; Abderrahman Bouraoui; Virginie Ratovelomanana-Vidal; Jean-Pierre Genet; Béchir Ben Hassine. Synthesis of new 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides via directed ortho-metalation reaction. Comptes Rendus. Chimie, Volume 5 (2002) no. 8-9, pp. 611-621. doi : 10.1016/S1631-0748(02)01418-2. https://comptes-rendus.academie-sciences.fr/chimie/articles/10.1016/S1631-0748(02)01418-2/

Version originale du texte intégral

1 Introduction

Heterocycles involving an arylsulfamido moiety have been reported to possess a variety of interesting biological activities 〚1–5〛. For example, 1,2-benzothiazines with basic side chains 〚6〛 are claimed to be diuretic agents. Antithrombotic and lipid-regulating properties are observed for 1,2-benzothiazine-3-carboxamides 〚7〛. Antibacterial activity was found for several penicillin derivatives containing the 1,2-benzothiazinyl fragment 〚8〛. Many reports have referred to the anti-inflammatory analgesic and antipyretic activities found for a variety of 1,2-benzothiazines 〚9〛. An initial report by Lombardino et al. 〚10〛 indicated that potent anti-inflammatory activity was present in a series of 4-hydroxy-2H-1,2-benzothiazin-3-carboxamide 1,1-dioxides 1 (Fig. 1).

Owing to these important biological properties of the benzo- and the heterocyclic ring-fused 1,2-thiazines, many publications have presented interesting methods of their synthesis 〚11–20〛. Meanwhile a few synthetic approaches to 1,2-naphtothiazine derivatives have been developed in the literature. Kaufmann and Zobel 〚21〛 first prepared 2,3-dihydro-3-oxonaphtho-〚1,8-d,e〛-1,2-thiazine 1,1-dioxides 2. More recently, this compound was prepared by Lombardino according to a short process 〚22〛. Both Trummlitz 〚23〛 and Steiner 〚24〛 have prepared independently naphtho〚2,1-e〛-1,2-thiazine 3 analogues of 1. Trummlitz and co-workers 〚23〛 also reported the synthesis of N-substituted 2H-naphtho〚2,1-c〛-1,2-thiazin-4(3H)-one 1,1-dioxides 4 by ring expansion of 3-bromomethylnaphth-〚2,1-d〛-isothiazole 1,1-dioxides.

As part of our continued efforts to develop synthetically useful anionic aromatic reactions for the synthesis of biologically active compounds 〚25〛, we report a general route based on the well known directed ortho-metalation reaction 〚20〛 in our synthetic approach to 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a–i (Fig. 2). These heterocycles are analogues of the 1,2-benzothiazines derivatives that were required for biological activities evaluations and as starting materials to prepare new drugs.

Fig. 2
Synthesis of compounds 5a–i, 6a–i, and 7a–i.

2 Results and discussion

The aromatic directed ortho-metalation reaction has been developed into a broadly useful protocol for the regioselective construction of polysubstituted aromatics 〚26–29〛 and used in the efficient synthesis of several heterocyclic ring systems and bioactive compounds 〚30〛.

The process reported herein (Fig. 2), possibly driven by the Complex Induced Proximity Effect (CIPE) 〚31〛, constitutes a mild method for the LDA-mediated regiospecific conversion of N-(2-naphthylsulfonyl) amino amides 6a–i 〚32–36〛 readily available from commercial racemic or optically pure (S)-α-amino acids into a new 2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a–i. According to this process, it was possible to change substitution patterns at the C-3 position of compounds 7a–i.

In order to select the optimal reaction conditions for the synthesis of compounds 7a-i, we have carefully examined the ortho-metalation conditions carried out on aminoamides 6a or 6f by changing the base (nature and number of equivalents) and the temperature.

The results shown in Table 1 indicate the requirement of an excess of LDA for efficient ortho-lithiations and to improve the yields (entries 1 to 5). In addition of the possible α- and α’-amide carbanion formation, the excess of LDA also serves to displace the equilibrium between the complex formed by the association of the organolithium reagent and the Lewis basic functionality of the substrate and the coordinated ortho-lithiated species in favour of the latter complex 〚29,31〛.

Entry	Substrate	BM (equivalent)	Yield (%)^a
1	6a	LDA (2)	38
2	6a	LDA (3)	47
3	6a	LDA (4)	56
4	6f	LDA (2)	61
5	6f	LDA (3)	70
6	6f	LDA (3)^b	43
7	6f	LiHMDS (3)	64
8	6f	sec-BuLi (3)	33

The use of other bases, such as LiHMDS, sec-BuLi and n-BuLi, do not ameliorate the yield of products. With sec-BuLi, the cyclisation proceeds very poorly (entry 8), yielding a complex mixture of products. Moreover, either at 0 °C or at –78 °C, the exposure of (S)-N,N-diisopropyl-3-methyl-2-(N-2-naphthylsulfonylamino)butanamide 6a to n-BuLi gave the 2-methyl-3-(N-2-naphthylsulfonylamino)octan-4-one as a major product along with the starting material 6a. The ketone results from nucleophilic addition of n-BuLi to 6a before the directed ortho-lithiation reaction. In addition, we have found out that low temperature (–78 °C) decreases significantly the yield of the cyclisation reaction when LDA was used (compare entry 5 with entry 6).

Attempts of these different experimental conditions summarised in Table 1 led to the selection of the following procedure: treatment of compounds 6a–i with 〚LDA (four equivalents for N–H derivatives and three equivalents for N–Me derivatives)/THF /–5 to 25 °C over 1 h〛 gave the corresponding 2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a–i. However, the excess of LDA has racemised heterocycles prepared from enantiomerically pure intermediates 6a,c–h. Yields range between 21 and 70% (Table 2).

Table 2
Synthesis of 3-substituted-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a–i.

Theoretically, ortho-lithiation of N-(2-naphthylsulfonyl)amino amides 6a–i can occur on carbon-1 and carbon-3 of the naphthalene ring. Characterisation of the reaction product proves the regiospecific cyclisation of substrates 5 to provide exclusively 2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides 7a-i. To further prove the selectivity of H-3 deprotonation on expense of H-1 proton, lithiation–deuteration experiments with secondary and tertiary 2-naphthylsulfonamides 8 and 9 were undertaken (Fig. 3).

Fig. 3
Lithiation–deuteration experiments with secondary and tertiary 2-naphthylsulfonamides 8 and 9, giving 10 and 11.

Thus, treatment of N-methyl-2-naphthylsulfonamide 8 with n-BuLi (2.2 equiv), followed by quench with CD₃OD resulted in selective deuterium incorporation at carbon-3 (RMN ¹H). Likewise, N,N-diethyl-2-naphthylsulfonamide 9 when subjected to similar n-BuLi (1.1 equiv) metalation–CD₃OD quench conditions, afforded only the ortho-deuterated product at carbon-3 (Table 3). As metalation regioselectivity is influenced by variation of metalating agent 〚37〛, substrates 8 and 9 were metalated with 〚LDA (2.2 equiv for 8 and 1.1 equiv for 9)/THF/–5 °C to 25 °C〛. Aliquots were quenched at 0 °C and at room temperature during the course of the reaction by addition to CD₃OD. Deuterium incorporation obtained in these experiments was the same as that obtained when n-BuLi was used.

Product	RLi	Yield (%)
10	n-BuLi	79
10	LDA	38
11	n-BuLi	87
11	LDA	42

Both results of ortho-lithiation–cyclisation with compounds 5 and ortho-lithiation–deuteration with compounds 8 and 9 demonstrate that the orientation of the sulfonamide group with respect to the proton removed during the ortho-lithiation significantly affects the reaction course 〚38〛. These results lead also to the suggestion of a naphthalenesulfonyl-base complex (Fig. 4), which places the LDA in the proximity of H-3 proton so as to exert a regio-control by a CIPE process.

Fig. 4
Chemical route from 6 to 7, through a naphthalenesulfonyl-base complex, which places the LDA in the proximity of H-3 proton and so exerts regio-control by a CIPE process.

3 Conclusion

In summary, a systematic study has provided optimised conditions for the synthesis of new 2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxides analogues of the 1,2-benzothiazine class. The synthetic approach applied to elaborate these heterocycles was based on the directed ortho-metalation procedure. This reaction has significant advantages over the more traditional alkoxide-mediated ring expansion of N-acyl-1,2-arenethiazole 1,1-dioxides derivatives 〚13, 24〛, since it constitutes a general, convenient and regiospecific method for the synthesis of substituted 1,2-naphthothiazines. The selectivity of ortho-lithiation reactions of 6, 8 and 9 is reasonably attributed to a favourable arrangement during the transfer of the proton to the lithiating reagent within a complex of sulfonamide with the organolithium reagent.

The continuous pharmaceutical interest in the arylsulfonamide compounds 〚25, 39–40〛 may justify further exploration of these results in the pharmacological field.

4 Experimental section

All reactions were carried out under argon in dried glassware, using syringe-septum cap techniques. Solvents were purified and dried by standard methods. Melting points were determined on a Büchi SMP-20 capillary apparatus and are uncorrected. TLC was carried out on Merck 60F-254 precoated silica gel plates (0.25 mm) and column chromatography was performed with Merck silica gel (70–230 mesh). NMR spectra were recorded on a Bruker 300 spectrometer (¹H at 300 MHz and ¹³C at 75 MHz) with CDCl₃ as solvent and TMS as internal standard reference. IR–TF spectra were recorded on a BIORAD FTS-6000 spectrometer. Mass spectra (EI) were recorded on a Hewlett Packard 5792 apparatus coupled to a GC HP-5890 chromatograph (column: 5% diphenyl, 95% dimethylpolysiloxane. 25 m × 0.25 mm ID, 0.35 μm film). Elemental analyses were carried out by the ‘Service de microanalyse’ of the University Paris-6. Optical rotations were measured at 21 °C on a Perkin-Elmer 241 polarimeter. n-BuLi and sec-BuLi were purchased from Acros as solutions in hexane stored in a resealable container, and titrated periodically against sec-butanol 〚41〛.

4.1 N-(2-Naphthylsulfonyl)-2-amino acids 5a-e and 5h,i. General procedure

To a solution of an α-amino acid (20 mmol) in aqueous NaOH (2M, 10 ml, 20 mmol) at 0 °C was added 2-naphthylsulfonyl chloride (21 mmol, 1.05 equiv), followed by EtN(i-Pr)₂ (22 mmol, 1.1 equiv) and acetone (10 ml). The mixture was stirred at room temperature for 12 h. The reaction mixture was washed with Et₂O (2 × 50 ml) and the combined washings extracted with aqueous NaOH (2M, 10 ml). The combined basic aqueous layers were cooled to 0 °C and acidified (pH 1) by the addition of concentrated HCl. The mixture was extracted with EtOAc (3 × 50 ml), dried over MgSO₄, filtered and concentrated under reduced pressure to give N-(2-naphthylsulfonyl)-2-amino acids, which were purified by crystallisation.

4.2 (S)-3-Methyl-2-(N-2-naphthylsulfonylamino)butanoic acid: 5a

Yield 78%. mp 103–105 °C. 〚α〛_D = –19.2 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 0.88 (d, 3H, J = 6.8 Hz), 0.97 (d, 3H, J = 6.8 Hz), 2.15 (m, 1H), 3.79 (dd, 1H, J = 4.6 Hz and 9.8 Hz), 5.27 (d, 1H, J = 9.8 Hz), 7.54–7.63 (m,2H), 7.77–7.94 (m, 4H), 8.35 (s, 1H), 9.45 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 16.64, 19.17, 28.23, 63.59, 123.94, 126.36, 127.32, 129.37, 130.56, 130.29, 130.96, 133.58, 133.80, 137.28, 173.55.

4.3 (±)-2-(N-2-Naphthylsulfonylamino)propanoic acid: 5b

Yield 83%. mp 151–105 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.22 (d, 3H, J = 7.4 Hz), 3.83 (qd, 1H, J = 7.4 Hz and J = 6.5 Hz), 5.56 (d, 1H, J = 6.5 Hz), 7.60–7.71 (m, 2H), 7.80–7.96 (m, 4H), 8.40 (s, 1H), 9.9 (br,1H). – ¹³C NMR (75 MHz, CDCl₃): δ = 38.36, 57.03, 122.63, 126.59, 128.67, 129.11, 129.87, 131.03, 131.65, 134.78, 135.13, 138.43, 172.98.

4.4 (S)-3-Methylsulfanyl-2-(N-2-naphthylsulfonylamino)propanoic acid: 5c

Yield 77%. mp 93–94 °C. 〚α〛_D = –15.6 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 3.28 (m, 2H), 3.75 (s, 3H), 4.23 (m, 1H), 6.32 (d, 1H, J = 9.8 Hz), 7.59–7.68 (m, 2H), 7.73–7.90 (m, 4H), 8.38 (s, 1H), 9.60 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 18.76, 41.46, 55.79, 124.15, 126.36, 128.65, 129.32, 130.56, 131.08, 131.98, 133.40, 134.74, 137.36, 172.36.

4.5 (S)-3-Phenyl-2-(N-2-naphthylsulfonylamino)propanoic acid: 5d

Yield 84%. mp 133–134 °C. 〚α〛_D = –43.2 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 3.15 (m, 2H), 3.98 (m, 1H), 5.59 (d, 1H, J = 10.0 Hz), 7.66–7.74 (m, 7H), 7.86–8.04 (m, 4H), 8.46 (s, 1H), 10.16 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 42.38, 57.17, 124.69, 125.61, 126.75, 127.14, 127.61, 128.07, 128.66, 129.14, 129.86, 131.55, 132.18, 135.73, 138.26, 139.10, 175.44.

4.6 (2S, 3S)-3-Methyl-2-(N-2-naphthylsulfonylamino)pentanoic acid: 5e

Yield 70%. mp 111–112 °C. 〚α〛_D = –8.4 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 0.92 (d, 3H, J = 5.4 Hz), 1.18 (t, 3H, J = 3.5 Hz), 1.25–1.39 (m, 2H), 2.48–2.55 (m, 1H), 4.12–4.20 (dd, 1H, J = 3.3 and J = 10.0 Hz), 5.25–5.30 (d, 1H, J = 10.0 Hz), 7.58–7.69 (m, 2H), 7.81–7.96 (m, 4H) 8.28 (s, 1H), 9.6 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 12.03, 14.52, 25.71, 34.36, 62.41, 122.69, 125.33, 127.74, 128.72, 129.13, 130.48, 131.11, 133.67, 134.10, 137.15, 173.19.

4.7 (S)-N-(2-Naphthylsulfonyl)pipecolinic acid: 5h

Yield 75%. mp 131–132 °C. 〚α〛_D = –35.0 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 0.9–1.1 (m, 1H), 1.4–1.6 (m, 4H), 2.5–2.7 (m, 2H), 3.39 (dt, 1H, J = 3.5 Hz and J = 10.8 Hz), 5.34 (t, 1H, J = 3.5 Hz), 7.53–7.64 (m, 2H), 7.79–7.98 (m, 4H), 8.42 (s, 1H), 9.95 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 20.17, 24.15, 24.36, 45.59, 61.82, 123.63, 126.28, 128.93, 129.71, 130.79, 131.09, 131.69, 133.73, 134.44, 137.48, 174.42.

4.8 (±)-N-(2-Naphthylsulfonyl)proline: 5i

Yield 74%. mp 128–130 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.76–1.82 (m, 2H), 2.18–2.32 (m, 2H), 3.34–3.52 (m, 2H), 4.30 (dt, 1H, J = 4.1 Hz and J = 10.7 Hz), 7.61–7.72 (m, 2H), 7.83–8.02 (m, 4H), 8.28 (s, 1H), 9.7 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 24.96, 31.18, 47.96, 59.42, 123.80, 126.65, 128.73, 129.51, 130.39, 130.36, 131.31, 133.49, 134.33, 137.47, 172.52.

4.9 N-Methyl-N-(2-naphthylsulfonyl)-2-amino acids 5f,g. General procedure

N-(2-naphthylsulfonyl)-2-amino acid was suspended in 150 ml of toluene, and paraformaldehyde (2 g) and p-toluenesulfonic acid (200 mg) were added. The mixture was refluxed for 30 min with azeotropic water removal. The solution was then cooled, washed with 1 N aqueous NaHCO₃ (2 × 50 ml) and dried over MgSO₄. Concentration in vacuo gave the corresponding N-(2-naphthylsulfonyl)oxazolidinone, without further purification was dissolved in 20 ml of CHCl₃ and 20 ml of trifluoroacetic acid and triethylsilane (30 mmol) were added. The solution was stirred at room temperature for 24 h; subsequent concentration in vacuo and purification by crystallisation gave pure N-methyl-N-(2-naphthylsulfonyl)-2-amino acid.

4.10 (S)-3-Methyl-2-(N-methyl-N-2-naphthylsulfonylamino)butanoic acid: 5f

Yield 81%. mp 116–117 °C. 〚α〛_D = –25.1 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 0.89 (d, 3H, J = 7.2 Hz), 1.13 (d, 3H, J = 7.2 Hz), 2.48 (m, 1H), 2.52 (s, 3H), 4.36 (d, 1H, J = 3.3 Hz), 7.54–7.64 (m,2H), 7.81–7.97 (m, 4H), 8.37 (s, 1H), 10.5 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 17.19, 19.38, 27.86, 38.60, 63.19, 123.78, 126.46, 128.73, 128.98, 130.20, 130.52, 131.25, 133.49, 134.35, 136.88, 172.23.

4.11 (S)-3-Phenyl-2-(N-methyl-N-2-naphthylsulfonylamino)propanoic acid: 5g

Yield 95%. mp 139–141 °C. 〚α〛_D = –48.5 (c1, MeOH). ¹H NMR (300 MHz, CDCl₃): δ = 2.20 (s, 3H), 3.19 (d, 2H, J = 3.9 Hz), 4.24 (t, 1H, J = 3.9 Hz), 7.37–7.58 (m, 7H), 7.78–7.94 (m, 4H), 8.27 (s, 1H), 9.40 (br, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 37.56, 41.61, 56.31, 128.53, 128.94, 129.09, 129.58, 130.01, 130.75, 131.29, 131.96, 133.01, 133.87; 134.25, 134.86, 135.75, 136.93, 173.15.

4.12 N,N-Diisopropyl-2-amino amides 6a–i. General procedure

To a stirred solution of N-(2-naphthylsulfonyl)-2-amino acid or N-methyl-N-(2-naphthylsulfonyl)-2-amino acid (10 mmol) in dry benzene (70 ml), was added at room temperature SOCl₂ (12 mmol, 1.2 equiv). The mixture was then refluxed for 3 h, cooled and concentrated to oil. The oil was dissolved in CH₂Cl₂ and reconcentrated two times. The corresponding acid chloride obtained, without further purification, was dissolved in 50 ml of CH₂Cl₂ and added to a stirred solution of diisopropylamine (11 mmol) and triethylamine (11 mmol) in CH₂Cl₂ (30 ml). The mixture was stirred at 0 °C for 2 h and then poured into 100 ml of a diluted HCl solution. The N,N-diisopropyl-2-amino amide was extracted with CH₂Cl₂ and the organic phase was washed with saturated NaCl solution, dried over MgSO₄, filtered and concentrated. The residue was purified by silica gel chromatography 〚SiO₂; (EtOAc:hexane)〛 to afford the N,N-diisopropyl-2-amino amide.

4.13 (S)-N,N-Diisopropyl-3-methyl-2-(N-2-naphthylsulfonylamino)butanamide: 6a

Yield 84%. mp 118–121 °C. 〚α〛_D = –31.9 (c1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.85 (d, 3H, J = 7.0 Hz), 1.11 (d, 3H, J = 7.0 Hz), 1.14–1.29 (m, 12H), 2.88 (m, 1H), 3.05–3.13 (m, 2H), 4.36 (dd, 1H, J = 4.1 Hz and 10.18 Hz), 5.50 (d, 1H, J = 10.1 Hz), 7.61–7.71 (m, 2H), 7.82–8.9 (m, 4H), 8.44 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.05, 12.27, 12.86, 13.51, 16.71, 19.20, 29.02, 40.63, 41.37, 67.84, 123.86, 127.09, 128.73, 129.41, 130.17, 130.52, 131.42, 133.60, 134.19, 137.33, 168.61. C₁₅H₁₅NO₃S (390.54): calcd C 64.58, H 7.74; found C 64.47, H 7.81.

4.14 (±)-N,N-Diisopropyl-2-(N-2-naphthylsulfonylamino)propanamide: 6b

Yield 78%. mp 113–114 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.0–1.21 (m, 12H), 1.28 (d, 3H, J = 7.2 Hz), 3.11–3.25 (m, 2H), 3.84 (qd, 1H, J = 7.2 Hz and J = 6.5 Hz), 5.53 (d, 1H, J = 6.5 Hz), 7.73–7.85 (m, 2H), 7.80–7.98 (m, 4H), 8.32 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.13, 12.35, 13.06, 13.66, 38.31, 40.49, 41.32, 56.84, 123.62, 126.67, 128.70, 129.43, 130.37, 131.12, 131.53, 134.18, 134.62, 138.19, 167.79. C₁₅H₁₅NO₃S (362.49): calcd C 62.95, H 7.23; found C 62.89, H 7.26.

4.15 (S)-N,N-Diisopropyl-3-methylsulfanyl-2-(N-2-naphthylsulfonylamino)propanamide: 6c

Yield 79%. mp 102–103 °C. 〚α〛_D = –35 (c1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 1.09–1.26 (m, 12H), 3.02–3.24 (m, 2H), 3.37 (m, 2H), 3.68 (s, 3H), 4.40 (m, 1H), 6.53 (d, 1H, J = 10.5 Hz), 7.59–7.72 (m, 2H), 7.82–8.01 (m, 4H), 8.28 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.10, 12.33, 13.04, 13.47, 18.69, 40.58, 41.36, 41.55, 54.68, 123.61, 126.78, 128.73, 129.24, 130.42, 131.50, 132.25, 133.36, 134.25, 137.38, 168.39. C₁₅H₁₅NO₃S (376.51): calcd C 63.80, H 7.49; found C 63.96, H 7.43.

4.16 (S)-N,N-Diisopropyl-3-phenyl-2-(N-2-naphthylsulfonylamino)propanamide: 6d

Yield 80%. mp 153–155 °C. 〚α〛_D = –46.3 (c1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.89–1.02 (m, 12H), 3.02–3.18 (m, 2H), 3.47 (m, 2H), 4.58 (m, 1H), 6.52 (d, 1H, J = 10.1 Hz), 7.23–7.62 (m, 7H), 7.75–7.91 (m, 4H), 8.25 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.24, 12.43, 13.07, 13.60, 40.81, 41.56, 41.69, 53.79, 125.56, 125.78, 126.77, 127.15, 127.61, 128.31, 129.24, 129.69, 130.17, 131.82, 132.54, 135.70, 138.36, 139.58, 168.74. C₁₅H₁₅NO₃S (438.58): calcd C 68.46, H 6.89; found C 68.38, H 6.94.

4.17 (2S, 3S)-N,N-Diisopropyl-3-methyl-2-(N-2-naphthylsulfonylamino)pentanamide: 6e

Yield 78%. mp 106–107 °C. 〚α〛_D = –29.7 (c1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.95–1.29 (m, 15H), 1.32–1.49 (m, 5H,), 2.72–2.80 (m, 1H), 3.05–3.18 (m, 2H), 4.61–4.73 (dd, 1H, J = 3.2 and J = 8.5 Hz), 5.33–5.46 (d, 1H, J = 10.1 Hz), 7.60–7.72 (m, 2H), 7.84–8.02 (m, 4H) 8.39 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.16, 11.49, 12.32, 12.91, 13.62, 15.28, 25.83, 34.66, 40.82, 42.05, 67.68, 123.16, 125.59, 127.87, 128.59, 129.69, 130.99, 131.63, 133.43, 134.46, 137.21, 168.32. C₁₅H₁₅NO₃S (404.57): calcd C 65.31, H 7.97; found C 65.42, H 7.91.

4.18 (S)-N,N-Diisopropyl-3-methyl-2-(N-methyl-N-2-naphthylsulfonylamino)butanamide: 6f

Yield 85%. mp 121–123 °C. 〚α〛_D = –27.3 (c 1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.93 (d, 3H, J = 7.2 Hz), 1.10 (d, 3H, J = 7.2 Hz), 1.13–1.29 (m, 12H), 2.57 (m, 1H), 3.01 (s, 3H), 3.14–3.28 (m, 2H), 4.49 (d, 1H, J = 3.5 Hz), 7.66–7.71 (m, 2H), 7.72–7.89 (m, 4H), 8.37 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.32, 12.18, 12.88, 13.57, 17.19, 19.24, 27.86, 38.76, 41.09, 42.11, 68.01, 123.82, 126.58, 128.25, 129.39, 130.52, 131.28, 131.85, 133.48, 134.68, 137.72, 169.14. C₁₅H₁₅NO₃S (404.57): calcd C 65.31, H 7.97; found C 65.40, H 7.94.

4.19 (S)-N,N-Diisopropyl-3-phenyl-2-(N-methyl-N-2-naphthylsulfonylamino)propanamide: 6g

Yield 77%. mp 129–130 °C. 〚α〛_D = –31.5 (c 1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.92–1.11 (m, 12H), 2.34 (s, 3H), 3.12–3.22 (m, 2H), 3.41 (d, 2H, J = 3.7 Hz), 4.37 (t, 1H, J = 3.7 Hz), 7.47–7.62 (m, 7H), 7.86–7.90 (m, 4H), 8.29 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.29, 12.37, 12.74, 13.71, 37.15, 40.93, 41.73, 42.57, 54.39, 128.17, 128.24, 128.69, 129.10, 129.49, 130.08, 130.96, 131.87, 132.11, 133.27; 133.65, 134.54, 135.69, 136.81, 167.58. C₁₅H₁₅NO₃S (452.61): calcd C 68.99, H 7.12; found C 68.90, H 7.21.

4.20 (S)-N,N-Diisopropyl-2-(N-2-naphthylsulfonyl)pipecolinamide: 6h

Yield 82%. mp 138–140 °C. 〚α〛_D = –16.4 (c 1, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 1.03–1.28 (m, 12H), 1.32–1.37 (m,1H), 1.57–1.79 (m, 4H), 2.37–2.65 (m, 2H), 3.10–3.19 (m, 2H), 3.64 (dt, 1H, J = 4.2 Hz and J = 11.9 Hz), 5.46 (t, 1H, J = 4.2 Hz), 7.55–7.66 (m, 2H), 7.91–8.10 (m, 4H), 8.47 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.23, 12.29, 12.82, 13.67, 21.10, 24.37, 25.21, 40.80, 41.93, 46.31, 62.72, 123.69, 127.41, 128.74, 129.65, 130.46, 130.59, 131.37, 133.76, 134.41, 137.49, 169.04. C₁₅H₁₅NO₃S (402.55): calcd C 65.64, H 7.51; found C 65.68, H 7.48.

4.21 (±)-N,N-diisopropyl-2-(N-2-naphthylsulfonyl)prolinamide: 6i

Yield 78%. mp 134–135 °C. ¹H NMR (300 MHz, CDCl₃): δ = 0.98–1.21 (m, 12H), 1.53–1.67 (m, 2H), 2.16–2.35 (m, 2H), 3.02–3.18 (m, 2H), 3.56–3.78 (m, 2H), 4.87 (dt, 1H, J = 3.7 Hz and J = 11.0 Hz), 7.64–7.70 (m, 2H), 7.84–7.99 (m, 4H), 8.39 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.09, 12.37, 13.05, 13.74, 23.66, 32.17, 48.32, 56.41, 123.98, 126.53, 128.87, 130.28, 130.86, 131.11, 131.73, 133.68, 134.69, 137.79, 168.31. C₁₅H₁₅NO₃S (388.52): calcd C 64.92, H 7.26; found C 65.09, H 7.30.

4.22 2H-1,2-Naphthothiazin-4(3H)-one 1,1-dioxides 7a–i. General procedure

To a solution of LDA (4 equiv for N–H derivatives and 3 equiv for N–Me derivatives of 6) freshly prepared in THF at –5 °C was added dropwise a solution of N-(2-naphthylsulfonyl)amino amide (5 mmol). The reaction mixture was allowed to warm to room temperature over 1 h, and then quenched with a hydrochloric acid solution (1 M, 25 ml). The organic layer was separated and the aqueous layer extracted with methylene chloride (3 × 20 ml). The organic extracts were dried (Na₂SO₄), and evaporated. The residue was purified by silica gel chromatography 〚SiO₂; (EtOAc:hexane)〛 to afford the 2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide.

4.23 3-Isopropyl-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7a

Yield 56%. mp 145–147 °C. ¹H NMR (300 MHz, CDCl₃): δ = 0.98 (d, 3H, J = 6.9 Hz), 1.17 (d, 3H, J = 6.9 Hz), 2.85 (m, 1H), 4.48 (dd, 1H, J = 3.6 Hz and 10.2 Hz), 5.47 (d, 1H, J = 10.2 Hz), 7.65 (m,2H), 7.85 (m, 2H), 8.15 (s, 1H), 8.45 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 16.66, 19.19, 28.26, 68.45, 123.90, 126.56, 128.79, 129.27, 130.18, 130.36, 131.11, 133.63, 134.10, 137.21, 191.91. IR (KBr): ν = 1679 (C=O), 1128, 1323 (SO₂N), 1552 (NH), 1044 (SO₂). C₁₅H₁₅NO₃S (289.33): calcd C 62.26, H 5.22; found C 62.34, H 5.30.

4.24 3-Methyl-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7b

Yield 40%. mp 126–128 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.33 (d, 3H, J = 7.2 Hz), 3.92(qd, 1H, J = 7.2 Hz and J = 6.6 Hz), 5.63 (d, 1H, J = 6.6 Hz), 7.70 (m, 2H), 7.82 (m, 2H), 8.12 (s, 1H), 8.51 (s,1H). ¹³C NMR (75 MHz, CDCl₃): δ = 38.49, 56.94, 123.91, 126.51, 128.72, 129.32, 130.29, 130.33, 131.22, 134.01, 134.72, 138.13, 192.90. IR (KBr): ν = 1669 (C=O), 1126, 1339 (SO₂N), 1569 (NH), 1048 (SO₂). C₁₃H₁₁NO₃S (261.28): calcd C 59.75, H 4.23; found C 59.62, H 4.31.

4.25 3-Methylsulfanylmethyl-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7c

Yield 52%. mp 175–177 °C. ¹H NMR (300 MHz, CDCl₃): δ = 3.32 (m, 2H), 3.91 (s, 3H), 4.45 (m, 1H), 6.60 (d, 1H, J = 10.6 Hz), 7.62 (m, 2H), 7.83 (m, 2H), 8.21 (s, 1H), 8.50 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 18.78, 41.57, 53.98, 123.89, 126.46, 128.61, 129.34, 130.28, 130.38, 131.25, 133.56, 134.18, 137.30, 198.18. IR (KBr): ν = 1695 (C=O), 1125, 1323 (SO₂N), 1570 (NH), 1032 (SO₂). C₁₄H₁₃NO₃S₂ (307.38): calcd C 54.70, H 4.25; found C 54.81, H 4.29.

4.26 3-Benzyl-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7d

Yield 48%. mp 132–134 °C. ¹H NMR (300 MHz, CDCl₃): δ = 3.41 (m, 2H), 4.46 (m, 1H), 6.66 (d, 1H, J = 10.2 Hz), 7.26–7.61 (m, 7H), 7.87–7.94 (m, 2H), 8.06 (s, 1H), 8.10 (s, 1H). – ¹³C NMR (75 MHz, CDCl₃): δ = 41.56, 54.08, 125.62, 125.71, 126.81, 127.12, 127.71, 128.16, 128.59, 128.74, 129.00, 131.62, 132.04, 135.90, 138.18, 139.03, 198.08. IR (KBr): ν = 1671 (C=O), 113, 1326 (SO₂N), 1549 (NH), 1050 (SO₂). C₁₉H₁₅NO₃S (337.38): calcd C 67.64, H 4.47; found C 67.48, H 4.34.

4.27 3-(1-(S)-Methylpropyl)-2H-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7e

Yield 50%. mp 112–114 °C. ¹H NMR (300 MHz, CDCl₃): δ = 0.95 (d, 3H, J = 5.2 Hz), 1.01 (t, 3H, J = 3.5 Hz), 1.09–1.31 (m, 2H), 2.58–2.71 (m, 1H), 4.54–4.72 (dd, 1H, J = 3.2 and J = 10.1 Hz), 5.21–5.33 (d, 1H, J = 10.1 Hz), 7.64–7.76 (m, 2H), 7.95–8.01 (m, 2H) 8.25 (s, 1H), 8.56 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 11.5, 14.62, 25.92, 34.72, 67.45, 122.90, 125.55, 127.76, 128.69, 129.24, 130.35, 131.14, 133.53, 134.18, 137.01, 194.85. IR (KBr): ν = 1687 (C=O), 1139, 1313 (SO₂N), 1558 (NH), 1034 (SO₂).

4.28 3-Isopropyl-N-methyl-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7f

Yield 70%. mp 152–154 °C. ¹H NMR (300 MHz, CDCl₃): δ = 0.96 (d, 3H, J = 7.0 Hz), 1.18 (d, 3H, J = 7.0 Hz), 2.40 (m, 1H), 2.82 (s, 3H), 4.47 (d, 1H, J = 3.5 Hz), 7.67 (m,2H), 7.86 (m, 2H), 8.17 (s, 1H), 8.46 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 16.49, 19.03, 27.96, 38.65, 68.07, 123.88, 126.49, 128.66, 129.41, 130.22, 130.40, 131.09, 133.58, 134.18, 137.11, 191.72. IR (KBr): ν = 1672 (C=O), 1138, 1342 (SO₂N), 2810 (NCH₃), 1040 (SO₂). C₁₆H₁₇NO₃S (303.36): calcd. C 63.34, H 5.64; found C 63.22, H 5.61.

4.29 3-Benzyl-N-methyl-1,2-naphthothiazin-4(3H)-one 1,1-dioxide: 7g

Yield 62%. mp 138–140 °C. ¹H NMR (300 MHz, CDCl₃): δ = 2.29 (s, 3H), 3.38 (d, 2H, J = 3.8 Hz), 4.33 (t, 1H, J = 3.8 Hz), 7.25–7.77 (m, 7H), 7.87–7.93 (m, 2H), 8.08 (s, 1H), 8.10 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 37.11, 42.06, 54.21, 128.03, 128.34, 128.49, 129.12, 129.21, 129.65, 130.86, 131.76, 132.21, 133.03; 133.75, 134.00, 135.35, 136.51, 197.71. IR (KBr): ν = 1675 (C=O), 1132, 1340 (SO₂N), 2817 (NCH₃), 1047 (SO₂). C₂₀H₁₇NO₃S (351.40): calcd C 68.35, H 4.87; found C 68.48, H 5.01.

4.30 2,3,4,5-tetrahydropyrido〚1,2-b〛〚1,2〛naphthothiazin-7-one 12,12-dioxide: 7h

Yield 46%. mp 98–101 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.1–1.4 (m, 1H), 1.5–1.8 (m, 4H), 2.4–2.7 (m, 2H), 3.66 (dt, 1H, J = 3.6 Hz and J = 11.4 Hz), 5.23 (t, 1H, J = 3.6 Hz), 7.61–7.66 (m, 2H), 7.82–7.86 (m, 2H), 8.12 (s, 1H), 8.47 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 20.10, 24.22, 24.31, 46.16, 63.92, 123.81, 127.01, 128.82, 129.55, 130.29, 130.46, 131.19, 133.78, 134.30, 137.42, 192.94. IR (KBr): ν = 1692 (C=O), 1127, 1343 (SO₂N), 1042 (SO₂). C₁₆H₁₅NO₃S (301.35): calcd C 63.77, H 5.01; found C 63.54, H 5.11.

4.31 2,3,4- trihydropyrro〚1,2-b〛〚1,2〛naphthothiazin-6-one 11,11-dioxide: 7i

Yield 21%. mp 86–88 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.80–1.92 (m, 2H), 2.05–2.22 (m, 2H), 3.45–3.62 (m, 2H), 4.70 (dt, 1H, J = 3.9 Hz and J = 10.9 Hz), 7.63–7.68 (m, 2H), 7.83–7.87 (m, 2H), 8.16 (s, 1H), 8.49 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 24.76, 31.14, 48.17, 57.43, 123.90, 126.93, 128.75, 129.48, 130.16, 130.37, 131.15, 133.61, 134.23, 137.51, 193.16. IR (KBr): ν = 1689 (C=O), 1130, 1335 (SO₂N), 1040 (SO₂). C₁₅H₁₃NO₃S (287.32): calcd C 62.70, H 4.55; found C 62.75, H 4.42.

4.32 N-methyl-2-naphthylsulfonamide: 8

To a solution of 2-naphthylsulfonyl chloride (10 mmol) in CH₂Cl₂ (50 ml) stirred at 0 °C was added dropwise a solution of methylamine 30% in water (22 mmol). The reaction mixture was allowed to warm to room temperature over 1 h. Water (30 ml) was then added, and the aqueous phase was extracted with CH₂Cl₂ (3 × 30 ml). The extract was dried (Na₂SO₄), subjected to filtration and concentrated. The residue was purified by flash column chromatography 〚SiO₂; (EtOAc:cyclohexane)〛.

Yield 88%. mp 101–102 °C. ¹H NMR (300 MHz, CDCl₃): δ = 2.76 (d, 3H, J = 5.3 Hz), 5.45 (q, 1H, J = 5.3 Hz), 7.56–7.67 (m, 2H), 7.78–7.95 (m, 4H), 8.32 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 29.91, 122.69, 127.33, 127.73, 128.25, 128.60, 128.88, 129.12, 131.86, 134.23, 136.61.

4.33 N,N-Diethyl-2-naphthylsulfonamide: 9

To a solution of diethylamine (12 mmol) and triethylamine (12 mmol) in CH₂Cl₂ (100 ml) stirred at 0 °C was added dropwise a solution of 2-naphthylsulfonyl chloride (10 mmol) in CH₂Cl₂ (30 ml). The reaction mixture was allowed to warm to room temperature over 1 h. Water (30 ml) was then added, and the aqueous phase was extracted with CH₂Cl₂ (3 × 30 ml). The extract was dried (Na₂SO₄), subjected to filtration and concentrated. The residue obtained was purified by flash column chromatography 〚SiO₂; (EtOAc:cyclohexane)〛.

Yield 92%. mp 89–91 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.15 (t, 6H, J = 6.9 Hz), 3.24 (q, 4H, J = 6.9 Hz), 7.65–7.78 (m, 2H), 7.84–7.98 (m, 4H), 8.25 (s, 1H). ¹³C NMR (75 MHz, CDCl₃): δ = 16.38, 37.42, 122.58, 127.41, 127.86, 128.11, 128.74, 129.05, 129.32, 131.56, 134.85, 135.96.

4.34 Deuteration experiments

4.34.1 Using n-BuLi. General procedure

A solution of 8 or 9 in THF (0.5 M) was cooled to –5 °C under argon atmosphere and treated with n-BuLi in hexane (2.2 and 1.1 equiv, respectively). After stirring at –5 °C for 20 min, the reaction mixture was warmed quickly to room temperature and stirred for an additional 1 h before quenching with CD₃OD (10 equiv). The resulting solution was stirred for 1 h and quenched with saturated NH₄Cl solution. The aqueous portion was extracted with CH₂Cl₂, and the extract was dried (Na₂SO₄), subjected to filtration, and concentrated. The residue was purified by flash column chromatography 〚SiO₂; (EtOAc:cyclohexane)〛.

10. Use of the general procedure with the following materials 〚8 (0.221 g, 1 mmol), n-BuLi (0.88 ml, 2.5 M, 2.2 mmol), CD₃OD (0.40 ml, 10 mmol) in THF (10 ml)〛, followed by flash column chromatography (EtOAc/cyclohexane 2:8) afforded a light yellow solid. Yield 79%. ¹H NMR (300 MHz, CDCl₃): δ = 2.78 (d, 3H, J = 5.3 Hz), 5.21 (bs, 1H), 7.54–7.61 (m, 2H), 7.87–7.94 (m, 2H), 8.06 (s, 1H), 8.15 (s, 1H).

11. Use of the general procedure with the following materials 〚9 (0.263 g, 1 mmol), n-BuLi (0.44 ml, 2.5 M, 1.1 mmol), CD₃OD (0.40 ml, 10 mmol) in THF (10 ml)〛, followed by flash column chromatography (EtOAc/cyclohexane 2:8) afforded a light yellow solid. Yield 87%. ¹H NMR (300 MHz, CDCl₃): δ = 1.14 (t, 6H, J = 6.9 Hz), 3.22 (q, 4H, J = 6.94 Hz), 7.62–7.77 (m, 2H), 7.80–7.96 (m, 2H), 8.10 (s, 1H), 8.18 (s, 1H).

4.34.2 Using LDA. General procedure

A solution of 8 or 9 in THF (0.2 M) was cooled to –5 °C under argon atmosphere and treated with LDA (2.2 and 1.1 equiv, respectively, prepared by dropwise addition of n-BuLi to a solution of HN(i-Pr)₂ in THF (1 M) precooled to 0 °C). After stirring for 20 min, a 10 ml aliquot was quenched by addition to CD₃OD precooled to –5 °C. The reaction mixture was warmed to room temperature and stirred for an additional 1 h before quenching with CD₃OD. Each aliquot was extracted with CH₂Cl₂, and the extract was dried (Na₂SO₄), subjected to filtration, and concentrated. The residue was purified by flash column chromatography 〚SiO₂; (EtOAc:cyclohexane)〛.

Acknowledgements

We gratefully thank the DGRST, CMCU organisms and the ‘Ministère de l’Enseignement supérieur’ (Tunisia) for their generous support of our program.

Bibliographie

[〚1〛] V.J. Aran; P. Goya; C. Ochoa Adv. Heterocycl. Chem., 44 (1988), p. 81

[〚2〛] J.G. Lombardino; D.E. Kuhla Adv. Heterocycl. Chem., 28 (1981), p. 73

[〚3〛] M.S. Chamber; S.C. Hobbs; M.I. Graham; A.P. Watt; S.R. Fletcher; R. Baker; S.B. Freedman; S. Patel; A.J. Smith; V.G. Matassa Bioorg. Med. Chem. Lett., 5 (1995), p. 2303

[〚4〛] W.G. Rice; J.G. Supko; L. Malspeis; R.W. Buckheit; D. Clanton; M. Bu; L. Graham; C.A. Schaeffer; J.A. Turpin; J. Domagala; R. Gogliotti; J.P. Bader; S.M. Halliday; L. Coren; R.C. Sowder; L.O. Arthur; L.E. Henderson Science, 270 (1995), p. 1194

[〚5〛] E.S. Lazer; C.K. Miao; C.L. Cywin; R. Sorcek; H.C. Wong; Z. Meng; I. Potocki; M. Hoermann; R.J. Snow; M.A. Tschantz; T.A. Kelly; D.W. McNeil; S.J. Coutts; L. Churchill; A.G. Graham; E. David; P.M. Grob; W. Engel; H. Meier; G. Trummlitz J. Med. Chem., 40 (1997), p. 980

[〚6〛] T.M. Hasegawa; T. Furuta; T. Tsuda Japanese Patent 71/22,027, 1971

[〚7〛] J.G. Lombardino; E.H. Wiseman US Patent 3,862,319, 1975

[〚8〛] J.C. Sircar; H. Zinnes; J. Shavel US Patent 3,878,198, 1975

[〚9〛] J.G. Lombardino Antiinflammatory Agents: Chemistry and Pharmacology, Academic Press, New York, 1974 (p. 129)

[〚10〛] J.G. Lombardino; E.H. Wiseman; W. McLamore J. Med. Chem., 14 (1971), p. 1171

[〚11〛] J.G. Lombardino; E.H. Wiseman; J. Chiaini J. Med. Chem., 16 (1973), p. 493

[〚12〛] P. Catsoulacos; C. Camoutsis J. Heterocycl. Chem., 16 (1979), p. 1503

[〚13〛] R.A. Abramovitch; K.M. More; I. Shinkai; P.C. Srinivasan J. Chem. Soc. Chem. Commun. (1976), p. 771

[〚14〛] M.R. Panara; G. Renda; M.G. Sciulli J. Pharmacol. Exp. Ther, 290 (1999), p. 276

[〚15〛] C.B. Schapira; I.A. Perillo; S. Lamdan J. Heterocycl. Chem., 17 (1980), p. 1281

[〚16〛] I.A. Perillo; C.B. Schapira; S. Lamdan J. Heterocycl. Chem., 20 (1983), p. 155

[〚17〛] R. Pfister; P. Zeller; B. Binder; O. Hromatka Britsh Patent 2,003,877, 1979

[〚18〛] G. Trummlitz; W. Engel; E. Seeger; W. Haarmann; G. Engelhardt US Patent 4,137,313, 1979

[〚19〛] D. Binder; O. Hromatka; F. Geissler; K. Schmied; C.R. Noe; K. Burri; R. Pfister; K. Strub; P. Zeller J. Med. Chem., 30 (1987), p. 678

[〚20〛] W.I.I. Bakker; O.B. Familoni; J. Padfield; V. Snieckus Synlett (1997), p. 1079

[〚21〛] H. Kaufmann; H. Zobel Chem Ber. B, 55 (1922), p. 1499

[〚22〛] J.G. Lombardino J. Org. Chem., 36 (1971), p. 1843

[〚23〛] G. Trummlitz; E. Seeger; W. Engel; H. Teufel; G. Englehardt; W. Haarmann US Patent 3,992,535, 1976

[〚24〛] G. Steiner Justus Liebigs Ann. Chem. (1978), p. 635

[〚25〛] Y. Kacem; J. Kraiem; E. KerKeni; A. Bouraoui; B. Ben Hassine Eur. J. Pharm. Sci., 16 (2002), p. 221

[〚26〛] H.W. Gschwend; H.R. Rodriguez, Organic Reactions, vol. 1, Am. Chem. Soc, New York, 1979, p. 26

[〚27〛] I. Omae Chem. Rev., 79 (1979), p. 287

[〚28〛] V. Snieckus Bull. Soc. Chim. Fr., II (1988), p. 67

[〚29〛] V. Snieckus Chem. Rev., 90 (1990), p. 879

[〚30〛] N.S. Narasimhan; R.S. Mali Synthesis (1983), p. 957

[〚31〛] P. Beak; A.I. Meyers Acc. Chem. Res., 19 (1986), p. 356

[〚32〛] R.M. Freidinger; J.S. Hinkle; D.S. Perlow; B.H. Arison J. Org. Chem., 48 (1983), p. 77

[〚33〛] M.B. Berry; D. Craig Synlett (1992), p. 41

[〚34〛] P.J. Maurer; H. Takahata; H. Rapoport J. Am. Chem. Soc., 106 (1984), p. 1095

[〚35〛] F.B. Thomas; H. Rapoport J. Am. Chem. Soc., 103 (1981), p. 6157

[〚36〛] W.O. Moss; E. Wakefield; M.F. Mahon; K.C. Molloy; R.H. Bradbury; N.J. Hales; T. Gallagher Tetrahedron, 48 (1992), p. 7551

[〚37〛] P. Beak; R.A. Brown J. Org. Chem., 47 (1982), p. 34

[〚38〛] P. Beak; S.T. Kerrick; D.J. Gallagher J. Am. Chem. Soc., 115 (1993), p. 10628

[〚39〛] B.L. Eun; K.K. Soon; G.K. Sang Arch. Pharm. Res., 22 (1999), p. 44

[〚40〛] G. Dannhardt; W. Kiefer Eur. J. Med. Chem., 36 (2001), p. 109

[〚41〛] S.C. Watson; J.F. Eastham J. Organomet. Chem., 9 (1967), p. 165

Commentaires - Politique